APRIL PHARES: Open Payments
NPI 1508410754 · TAYLORSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,129 in 232 payments from 34 companies in 2025. Trend: 2023 $331 · 2024 $3,233 · 2025 $4,129
Food & beverage: $4,122Education: $7
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $506 |
| Axsome Therapeutics, Inc. | 19 | $410 |
| Otsuka America Pharmaceutical, Inc. | 22 | $406 |
| ABBVIE INC. | 30 | $388 |
| Amgen Inc. | 29 | $327 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $294 |
| ANI Pharmaceuticals, Inc. | 17 | $215 |
| PFIZER INC. | 10 | $213 |
| Novo Nordisk Inc | 11 | $154 |
| GlaxoSmithKline, LLC. | 6 | $116 |
Products named: REXULTI, Auvelity, Kerendia, BREZTRI, PURIFIED CORTROPHIN GEL, KRYSTEXXA, FARXIGA, UBRELVY.
Industry payments across NC — which companies pay providers there.
